These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 23124559)

  • 1. Influence of manufacturing factors on physical stability and solubility of solid dispersions containing a low glass transition temperature drug.
    Sakurai A; Sako K; Maitani Y
    Chem Pharm Bull (Tokyo); 2012; 60(11):1366-71. PubMed ID: 23124559
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polymer combination increased both physical stability and oral absorption of solid dispersions containing a low glass transition temperature drug: physicochemical characterization and in vivo study.
    Sakurai A; Sakai T; Sako K; Maitani Y
    Chem Pharm Bull (Tokyo); 2012; 60(4):459-64. PubMed ID: 22466729
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparative study of the effect of spray drying and hot-melt extrusion on the properties of amorphous solid dispersions containing felodipine.
    Mahmah O; Tabbakh R; Kelly A; Paradkar A
    J Pharm Pharmacol; 2014 Feb; 66(2):275-84. PubMed ID: 24433426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fusion production of solid dispersions containing a heat-sensitive active ingredient by hot melt extrusion and Kinetisol dispersing.
    Dinunzio JC; Brough C; Hughey JR; Miller DA; Williams RO; McGinity JW
    Eur J Pharm Biopharm; 2010 Feb; 74(2):340-51. PubMed ID: 19818402
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of HPMC based polymers performance as carriers for manufacture of solid dispersions using the melt extruder.
    Ghosh I; Snyder J; Vippagunta R; Alvine M; Vakil R; Tong WQ; Vippagunta S
    Int J Pharm; 2011 Oct; 419(1-2):12-9. PubMed ID: 21782911
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of surfactants as plasticizers in preparing solid dispersions of poorly soluble API: stability testing of selected solid dispersions.
    Ghebremeskel AN; Vemavarapu C; Lodaya M
    Pharm Res; 2006 Aug; 23(8):1928-36. PubMed ID: 16871443
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemically identical but physically different: A comparison of spray drying, hot melt extrusion and cryo-milling for the formulation of high drug loaded amorphous solid dispersions of naproxen.
    Dedroog S; Huygens C; Van den Mooter G
    Eur J Pharm Biopharm; 2019 Feb; 135():1-12. PubMed ID: 30529295
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A New Extrudable Form of Hypromellose: AFFINISOL™ HPMC HME.
    Huang S; O'Donnell KP; Keen JM; Rickard MA; McGinity JW; Williams RO
    AAPS PharmSciTech; 2016 Feb; 17(1):106-19. PubMed ID: 26335416
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of the molecular distribution of drugs in glassy solid dispersions at the nano-meter scale, using differential scanning calorimetry and gravimetric water vapour sorption techniques.
    van Drooge DJ; Hinrichs WL; Visser MR; Frijlink HW
    Int J Pharm; 2006 Mar; 310(1-2):220-9. PubMed ID: 16427226
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Site specific solubility improvement using solid dispersions of HPMC-AS/HPC SSL--mixtures.
    Zecevic DE; Meier R; Daniels R; Wagner KG
    Eur J Pharm Biopharm; 2014 Jul; 87(2):264-70. PubMed ID: 24768770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preparation of glass solutions of three poorly water soluble drugs by spray drying, melt extrusion and ball milling.
    Patterson JE; James MB; Forster AH; Lancaster RW; Butler JM; Rades T
    Int J Pharm; 2007 May; 336(1):22-34. PubMed ID: 17174493
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Using Flory-Huggins phase diagrams as a pre-formulation tool for the production of amorphous solid dispersions: a comparison between hot-melt extrusion and spray drying.
    Tian Y; Caron V; Jones DS; Healy AM; Andrews GP
    J Pharm Pharmacol; 2014 Feb; 66(2):256-74. PubMed ID: 24192445
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Application of melt extrusion in the development of a physically and chemically stable high-energy amorphous solid dispersion of a poorly water-soluble drug.
    Lakshman JP; Cao Y; Kowalski J; Serajuddin AT
    Mol Pharm; 2008; 5(6):994-1002. PubMed ID: 19434852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiple Linear Regression Modeling To Predict the Stability of Polymer-Drug Solid Dispersions: Comparison of the Effects of Polymers and Manufacturing Methods on Solid Dispersion Stability.
    Fridgeirsdottir GA; Harris RJ; Dryden IL; Fischer PM; Roberts CJ
    Mol Pharm; 2018 May; 15(5):1826-1841. PubMed ID: 29533634
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Formulation performance and processability window for manufacturing a dual-polymer amorphous solid dispersion via hot-melt extrusion and strand pelletization.
    Hörmann TR; Jäger N; Funke A; Mürb RK; Khinast JG; Paudel A
    Int J Pharm; 2018 Dec; 553(1-2):408-421. PubMed ID: 30326284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conjugation of Hot-Melt Extrusion with High-Pressure Homogenization: a Novel Method of Continuously Preparing Nanocrystal Solid Dispersions.
    Ye X; Patil H; Feng X; Tiwari RV; Lu J; Gryczke A; Kolter K; Langley N; Majumdar S; Neupane D; Mishra SR; Repka MA
    AAPS PharmSciTech; 2016 Feb; 17(1):78-88. PubMed ID: 26283197
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fusion processing of itraconazole solid dispersions by kinetisol dispersing: a comparative study to hot melt extrusion.
    DiNunzio JC; Brough C; Miller DA; Williams RO; McGinity JW
    J Pharm Sci; 2010 Mar; 99(3):1239-53. PubMed ID: 19681106
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tailoring the release rates of fluconazole using solid dispersions in polymer blends.
    Papageorgiou GZ; Bikiaris D; Kanaze FI; Karavas E; Stergiou A; Georgarakis E
    Drug Dev Ind Pharm; 2008 Mar; 34(3):336-46. PubMed ID: 18363150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of ternary solid dispersions of itraconazole, PEG 6000, and HPMC 2910 E5.
    Janssens S; de Armas HN; Roberts CJ; Van den Mooter G
    J Pharm Sci; 2008 Jun; 97(6):2110-20. PubMed ID: 17847067
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel supercritical carbon dioxide impregnation technique for the production of amorphous solid drug dispersions: a comparison to hot melt extrusion.
    Potter C; Tian Y; Walker G; McCoy C; Hornsby P; Donnelly C; Jones DS; Andrews GP
    Mol Pharm; 2015 May; 12(5):1377-90. PubMed ID: 25730138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.